89 related articles for article (PubMed ID: 23679074)
21. The surge of HBsAb level in a HBsAg-negative ES-SCLC patient after anlotinib plus atezolizumab treatment: A case report.
Chen G; Tian T; Cai X
Front Oncol; 2023; 13():1103512. PubMed ID: 37143951
[TBL] [Abstract][Full Text] [Related]
22. [Clinical significance and research progress of quantitative hepatitis B virus core antibody measurement].
Liu YQ; Zhang C; Zhao H; Wang GQ
Zhonghua Gan Zang Bing Za Zhi; 2024 Jan; 32(1):83-86. PubMed ID: 38320797
[TBL] [Abstract][Full Text] [Related]
23. Demyelinating neuropathy in patients with hepatitis B virus: A case report.
Yan XX; Huang J; Lin J
World J Clin Cases; 2024 Apr; 12(10):1766-1771. PubMed ID: 38660079
[TBL] [Abstract][Full Text] [Related]
24. Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies.
Anderson M; Holzmayer V; Stec M; Cloherty G; Lim SG
J Hepatol; 2023 Nov; ():. PubMed ID: 38036010
[No Abstract] [Full Text] [Related]
25. Reply to: "Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies".
Ghany MG; Buti M; Lampertico P; Lee HM
J Hepatol; 2024 Mar; ():. PubMed ID: 38462132
[No Abstract] [Full Text] [Related]
26. Loss of seroprotective antibody after a full series of hepatitis A virus vaccination in people with HIV.
Hung CC
Hepatol Res; 2024 May; 54(5):417-419. PubMed ID: 38573595
[No Abstract] [Full Text] [Related]
27. Roles of Hepatitis B Virus Mutations in the Viral Reactivation after Immunosuppression Therapies.
Inoue J; Nakamura T; Masamune A
Viruses; 2019 May; 11(5):. PubMed ID: 31109119
[TBL] [Abstract][Full Text] [Related]
28. HBV reactivation in allogeneic stem cell transplant recipients: Risk factors, outcome, and role of hepatitis B virus mutations.
Anastasiou OE; Almpani F; Herrmann A; Gerken G; Ditschkowski M; Ciesek S
Hepatol Commun; 2017 Dec; 1(10):1014-1023. PubMed ID: 29404439
[TBL] [Abstract][Full Text] [Related]
29. Quantifying perinatal transmission of Hepatitis B viral quasispecies by tag linkage deep sequencing.
Du Y; Chi X; Wang C; Jiang J; Kong F; Yan H; Wang X; Li J; Wu NC; Dai L; Zhang TH; Shu S; Zhou J; Yoshizawa JM; Li X; Bhattacharya D; Wu TT; Niu J; Sun R
Sci Rep; 2017 Aug; 7(1):10168. PubMed ID: 28860476
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal.
Cerva C; Maffongelli G; Svicher V; Salpini R; Colagrossi L; Battisti A; Mariotti B; Cerretti R; Cudillo L; Sarmati L
BMC Infect Dis; 2017 Aug; 17(1):566. PubMed ID: 28806922
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.
Pattullo V
World J Hepatol; 2015 May; 7(7):954-67. PubMed ID: 25954478
[TBL] [Abstract][Full Text] [Related]
32. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.
Kitano K; Kobayashi H; Hanamura M; Furuta K; Ueno M; Rokuhara A; Tanaka E; Umemura T; Kiyosawa K
Eur J Haematol; 2006 Sep; 77(3):255-8. PubMed ID: 16923112
[TBL] [Abstract][Full Text] [Related]
33. Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation.
Wu Y; Huang H; Luo Y
Front Immunol; 2020; 11():610500. PubMed ID: 33613534
[TBL] [Abstract][Full Text] [Related]
34. HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review.
Gentile G; Antonelli G
Viruses; 2019 Nov; 11(11):. PubMed ID: 31717647
[TBL] [Abstract][Full Text] [Related]
35. Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation.
Schubert A; Michel D; Mertens T
BMC Infect Dis; 2013 May; 13():223. PubMed ID: 23679074
[TBL] [Abstract][Full Text] [Related]
36. Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure.
Wong GL; Wong VW; Yuen BW; Tse YK; Yip TC; Luk HW; Lui GC; Chan HL
J Hepatol; 2020 Jan; 72(1):57-66. PubMed ID: 31499132
[TBL] [Abstract][Full Text] [Related]
37. Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT.
Viganò M; Vener C; Lampertico P; Annaloro C; Pichoud C; Zoulim F; Facchetti F; Poli F; Scalamogna M; Deliliers GL; Colombo M
Bone Marrow Transplant; 2011 Jan; 46(1):125-31. PubMed ID: 20383209
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
